Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Overactive Bladder”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Large-scale testing (Phase 3)Study completedNCT00915525
What this trial is testing

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Who this might be right for
Overactive BladderUrinary Incontinence
Allergan 829
Testing effectiveness (Phase 2)Study completedNCT01157377
What this trial is testing

Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence

Who this might be right for
Urinary Bladder, Overactive
Allergan 160
Not applicableStudy completedNCT02557971
What this trial is testing

Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Allergan 315
Not applicableLooking for participantsNCT07030803
What this trial is testing

Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation

Who this might be right for
Overactive Bladder (OAB)Transcutaneous NeurostimulationPosterior Tibial Nerve Stimulation
Centre Hospitalier Universitaire, Amiens 124
Early research (Phase 1)Study completedNCT03371342
What this trial is testing

Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder

Who this might be right for
Overactive Bladder
Medy-Tox 30
Testing effectiveness (Phase 2)Study completedNCT00746681
What this trial is testing

Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder

Who this might be right for
Overactive Bladder
Pfizer 188
Not applicableStudy completedNCT06345677
What this trial is testing

Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects

Who this might be right for
Overactive Bladder
Vensica Therapeutics Ltd. 48
Not applicableLooking for participantsNCT07366918
What this trial is testing

Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Pamukkale University 63
Not applicableStudy completedNCT04450511
What this trial is testing

Pelvic Floor Magnetic Stimulation in Women With Idiopathic Overactive Bladder

Who this might be right for
Urge Incontinence Episodes After the Magnetic Stimulation Added to Bladder Training in Women With Idiopathic Overactive Bladder
Pamukkale University 76
Not applicableNot Yet RecruitingNCT06662565
What this trial is testing

Effect of Pelvic Floor Down-training on Women With Idiopathic Overactive Bladder

Who this might be right for
Overactive Bladder
Cairo University 30
Not applicableStudy completedNCT03874780
What this trial is testing

Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder

Who this might be right for
Overactive Bladder
Vensica Therapeutics Ltd. 10
Large-scale testing (Phase 3)UnknownNCT04113941
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder

Who this might be right for
Overactive Bladder
Medy-Tox 216
Testing effectiveness (Phase 2)Ended earlyNCT00335660
What this trial is testing

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

Who this might be right for
Overactive Bladder Syndrome
Avera Pharmaceuticals 62
Large-scale testing (Phase 3)Study completedNCT00910520
What this trial is testing

Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Who this might be right for
Overactive Bladder
Allergan 548
Post-approval studies (Phase 4)Looking for participantsNCT04444440
What this trial is testing

Antibiotic Prophylaxis for Bladder Botox

Who this might be right for
Idiopathic Overactive BladderPostoperative Urinary Tract Infection
University of Alberta 202
Post-approval studies (Phase 4)Study completedNCT01054222
What this trial is testing

Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Pfizer 31
Not applicableStudy completedNCT00238680
What this trial is testing

Programmable Timer in the Bladder Rehabilitation Treatment of OAB

Who this might be right for
Overactive BladderUrinary Incontinence
University of Aarhus 100
Not applicableStudy completedNCT02161159
What this trial is testing

An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder

Who this might be right for
Urinary IncontinenceUrinary Bladder, Overactive
Allergan 515
Not applicableUnknownNCT01750645
What this trial is testing

Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic Review

Who this might be right for
Urinary Bladder, Overactive
Clínica Infantil Colsubsidio
Not applicableStudy completedNCT06484023
What this trial is testing

Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder

Who this might be right for
Overactive Bladder
Hopital Nord Franche-Comte 45
Load More Results